Home LiteratureArticle Details
PMID: 3720536 Published · ppublish English Journal Article

Intravenous self-administration of fencamfamine and cocaine by beagle dogs under fixed-ratio and progressive-ratio schedules of reinforcement.

Drug and alcohol dependence ·Vol. 17 ·No. 1 ·1986-05-00 ·Pages 93-102

Risner ME, Cone EJ

Abstract

Catheterized beagle dogs were given access to response-contingent intravenous injections of fencamfamine (FEN) or cocaine (COC) injections under a fixed-ratio (FR) schedule of reinforcement. Both drugs maintained self-administration behavior considerably above saline levels; there was an inverted U-shaped relationship between the number of injections per daily session and the dose per injection. Presession treatment with the dopaminergic antagonist pimozide (PIM) appreciably altered both the FEN and COC dose-effect curves, suggesting a dopaminergic component in the reinforcing properties of these substances. When tested under a progressive-ratio (PR) schedule, both FEN and COC maintained nearly identical FR-values which were considerably above those seen for saline. It appears from these data that FEN may have a cocaine-like abuse potential.

MeSH Terms
Animals Cocaine/administration & dosage,pharmacology Dogs Dose-Response Relationship, Drug Female Injections, Intravenous Male Norbornanes/administration & dosage,pharmacology Pimozide/pharmacology Reinforcement Schedule Self Administration
Chemicals
Norbornanes Pimozide Cocaine fencamfamine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Risner M E
Cone E J
Article Info
Journal
Drug and alcohol dependence
Abbr.
Drug Alcohol Depend
ISSN
0376-8716
Published
1986-05-00
Pages
93-102
Language
English
Region
Ireland
NLM ID
7513587
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com